David Goldfarb, MD
Enriched profileClinical Chief, Nephrology Division, NYU Langone Health; Professor of Medicine and Neuroscience, NYU Grossman School of Medicine · NYU Grossman School of Medicine
David Goldfarb is Clinical Chief, Nephrology Division, NYU Langone Health; Professor of Medicine and Neuroscience, NYU Grossman School of Medicine at NYU Grossman School of Medicine. OpenAlex indexes 500 publications with 23,611 citations (h-index 81); ClinicalTrials.gov lists 19 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Nephrology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
David Goldfarb, M.D., is Clinical Chief, Nephrology Division, NYU Langone Health at NYU Grossman School of Medicine / NYU Langone Health. The public record shows 500 publications with 23,611 citations (h-index 81), centered on Kidney Stones and Urolithiasis Treatments, Pediatric Urology and Nephrology Studies, Dialysis and Renal Disease Management. It also documents an investigator role on 19 registered clinical trials, industry payments reported by 11 companies, 11 NIH-funded awards (1986–2026).
- Most recent indexed publication: 2026 · Nature
- Top research focus: Kidney Stones and Urolithiasis Treatments
- 19 registered trials on ClinicalTrials.gov
- Open Payments reporting from 11 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 20 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 281.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 19 registered studies on ClinicalTrials.gov. The most recent:
- Tobacco Cessation at FDNY
Sponsor: Albert Einstein College of Medicine
- Gut Kidney Axis in Enteric Hyperoxaluria
Sponsor: NYU Langone Health
Industry payments
Updated 27 Aug 2026
11 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year20256 payments
- Alnylam Pharmaceuticals Inc.Program year202415 payments
- Novo Nordisk ASProgram year20246 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
55.2%Metabolic Alkalinizer51.8%Potassium Citrate Er100%Part D≥57 patientsPotassium supplement3.4%Potassium Chloride100%Part D<11 patientsCardiovascular
25%Thiazide-like diuretic18.8%Indapamide57%Chlorthalidone43%Part D<11 patientsLoop diuretic3.4%Furosemide100%Part D<11 patientsNervous system
7.3%Opioid Agonist/Antagonist3.9%Butorphanol Tartrate100%Part D<11 patientsOpioid Agonist3.4%Oxycodone-Acetaminophen100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
11 NIH research awards on record, funded 1986–2026 per NIH RePORTER. The latest:
- Identifying Undiagnosed Airway Dysfunction in WTC Responders Using Respiratory Oscillometry
Albert Einstein College of Medicine
FY2026$269,340R21OH012949 - Longitudinal Assessment of Hearing Loss in World Trade Center-Exposed Responders
Albert Einstein College of Medicine
FY2026$248,241R21OH012954 - Longitudinal Assessment of Hearing Loss in World Trade Center-Exposed Responders
Albert Einstein College of Medicine
FY2025$251,325R21OH012954
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- The Significance of Fibroblast Growth Factor 23 and 24,25-Dihydroxyvitamin D in Dent Disease Type 1.
Clinical journal of the American Society of Nephrology
Article2026 - Genetic and Clinical Characterization of a Large Cohort with Suspected Monogenic Stone Disease.
Clinical journal of the American Society of Nephrology
Article2025
Most-cited works
by citation count (OpenAlex)- 01Medical Management of Kidney Stones: AUA GuidelineArticle1,083 citations2014
- 02
- 03Importin α: a multipurpose nuclear-transport receptorArticle660 citations2004
- 04
- 05Synthetic peptides as nuclear localization signalsArticle474 citations1986
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/david-goldfarb-md-4d5caa3e
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Other
nyulangone.org/doctors/1629018908/david-s-goldfarb
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
Mentions by others
where others cite or feature them- Facebook
facebook.com/NKFGNY/videos/dr-goldfarb-clinical-chief-of-nephrology-at-nyu-langone-medical-center-presented/10155150078859874
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - Other
asn-online.org/about/bio.aspx
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asn-online.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rocksociety.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pubmed.ncbi.nlm.nih.gov ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asn-online.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
Secondary affiliations
appointments beyond the home institution- Chief
Nephrology Section, VA New York Harbor Healthcare System
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗ - Medical Director
Hemodialysis Unit, VA New York Harbor Healthcare System
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗ - Director
Kidney Stone Prevention Program, NYU Langone Health and New York VA Medical Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asn-online.org ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →renalandurologynews.com ↗
- Featured in DocWire News discussing Moonstone
an over-the-counter beverage marketed for kidney stone prevention
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →docwirenews.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →moonstonenutrition.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Jill Buyon, MD
NYU Grossman School of Medicine
Jeffrey Berger, MD
NYU Grossman School of Medicine
Mark Mulligan, MD
NYU Grossman School of Medicine
Harmony Reynolds, MD
NYU Grossman School of Medicine